本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
Deriv sets sight on global expansion, innovation, and a new era of leadership as it marks a major quarter-of-a-century milestone. New CSR framework launched to serve local and global communities through action-based sustainable and scalable initiatives. CYBERJAYA, Malaysia, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Deriv, a renowned broker in the financial industry is celebrating its 25th anniversary today, marking a quarter-century of growth and industry leadership. This milestone comes on the heels of exciting developments for the company, including a new co-leadership model, the opening of new offices in the UK and Senegal and several prestigious awards. Deriv has grown into a global leader in the online trading industry, currently serving over 2.5 million clients worldwide, and a $650B+ monthly volume. Its commitment to innovation has seen the company introduce new trading platforms, diverse asset classes, and comprehensive educational resources. “Today is a big day for Deriv. When I step back and look at how much we have grown and achieved since we started out 25 years ago, there is a lot of pride in our successes”, said Jean-Yves Sireau. “This is exactly what keeps us focused on everything Deriv wants to achieve in the next 25 years." Technology - especially AI and automation tools - will continue to be a critical factor in future-proofing Deriv’s operations for 2025 and beyond. The focus is on making systems more secure, protecting customer data, and staying compliant with regulations. These innovations will continue to give customers the best experience possible, ensuring Deriv remains competitive in a fast-changing digital world. Key highlights from Deriv's 25th anniversary year: Adopting a Dual Leadership model: Deriv undertook a huge shift in its management structure, promoting Rakshit Choudhary from COO to co-CEO alongside Deriv’s founder, Jean-Yves Sireau. The strategic change capitalised on the different strengths and diverse experience of the two leaders improving critical decision-making for the company as it doubled down on its growth strategy. 2024 Emerges as the Year of Award Wins: Reinforcing its successes, Deriv picked up awards for its products including ‘Affiliate Programme of the Year’ at the recent Forex Expo Dubai, ‘Best Customer Support’ at the Global Forex Awards and ‘Most Trusted Broker’ and ‘Best Trading Experience (LATAM)’ at the Ultimate Fintech Global Awards 2024. Accreditations for its Investment in People: Deriv was recognised as a top employer, receiving prestigious accreditations including ‘Investors in People Platinum’ and ‘Great Place to Work’ certifications across seven offices, named one of ‘Cyprus’s Best Workplaces™ 2024’ and ‘Best Workplaces™ in Financial Services and Insurance 2024’ in the UK. Global Office Expansion: Deriv opened a second office in the UK (London), along with establishing a new office in Rwanda. "Being recognised for our commitment to trust and service in our 25th year is especially meaningful," said Rakshit Choudhary, co-CEO at Deriv. With our eyes firmly set on global expansion, our people and our values will continue to steer us on our mission to make trading accessible to anyone, anywhere.” Making a Pledge to a Sustainable Future As part of its commitment to the future, Deriv has set out a long-term vision for social responsibility. Its purpose is to support projects that contribute to global sustainability and community well-being. Initiatives in 2024 included: Aided TECHO a youth-led nonprofit in Asunción, Paraguay, focused on housing solutions for communities Collaborated with DuHope, a Rwandan NGO helping women in need of support Supported Puttinu Cares, a children's cancer support group in Malta Backed the Kahuna Patagonia expedition, which combined adventurous endeavours with scientific, environmental research. “Beyond 2024, Deriv will expand its social responsibility initiatives across the regions where it operates. We are committed to creating a better future, making a positive impact by serving local and global communities through action-based, scalable and sustainable initiatives," added Sireau. Looking Ahead: Preparing for the Next 25 Years As Deriv reflects on its incredible history, the company is ready to continue pushing boundaries for another 25 years and beyond. With a future-proof leadership model, client-centric focus, and an eye for innovation, Deriv is well-positioned for the next era of growth. About Deriv For 25 years, Deriv has been committed to making online trading accessible to anyone, anywhere. Trusted by over 2.5 million traders worldwide, the company offers an expansive range of trade types and boasts over 300 assets across popular markets on award-winning, intuitive trading platforms. The company’s dedication to innovation and client satisfaction has earned it numerous accolades, including the recent ‘Best Customer Service’ award at the Global Forex Awards. PRESS CONTACT pr@deriv.com Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fb49cff6-578d-469c-ad47-50826695368b https://www.globenewswire.com/NewsRoom/AttachmentNg/96043286-f865-4b1e-be29-27a42cc7c07e https://www.globenewswire.com/NewsRoom/AttachmentNg/39d1d044-9541-4293-af43-07dcb70e2388
LOS ANGELES, Oct. 9, 2024 /PRNewswire/ -- Aghanim, a mobile gaming fintech company founded by Harvard Business School alumni with over 40 years of combined expertise in video games and fintech, today announces a strategic partnership with Sift, the AI-powered fraud decisioning platform securing digital trust for leading global businesses. The combination of AI-driven insights across 1 trillion events and identity signals combined with Aghanim's decades of expertise in gaming represents an unprecedented anti-fraud solution for mobile games. Founded in June 2023, Aghanim empowers mobile game publishers to unlock new revenue streams through direct-to-consumer strategies. Its web-based game hubs also drive value for players with exciting competitive, social, and metagame features and rewards in addition to targeted offers. By helping game developers and publishers increase their net revenue by up to 200%, Aghanim enables them to invest additional capital into vital areas such as user acquisition. Sift is an AI-powered fraud decisioning platform that helps digital businesses optimize their risk-reward equation with advanced machine learning, providing multi-layered fraud prevention for over 700 global businesses. With Sift's support, Aghanim customers are able to detect fraud, secure every transaction, and improve conversion & engagement. Constantin Andry, Co-founder and Co-CEO of Aghanim commented: "Aghanim offers mobile game studios a fully self-managed end-to-end solution, which includes web-based game hub creation and management, integrated e-commerce, live ops automation, community engagement, and a payments platform as a suite of interoperable tools. This partnership with Sift enables us to ensure game developers, publishers, and their players are as protected as possible via secure, compliant, direct-to-consumer web-based solutions." Armen Najarian, Chief Marketing Officer at Sift said: "Aghanim is an exciting player in the fintech world, and one with the potential to solve some of the inherent challenges in mobile gaming. We look forward to supporting their mission as the leading direct-to-consumer platform for mobile games by preventing fraud and creating a trusted, safe environment for their users." Aghanim soft-launched in early 2024 with funding from Bessemer Venture Partners, Point72 Ventures, QED Investors, and the A16Z GAMES SPEEDRUN. The company is rapidly expanding its reach and partnering with major mobile games companies to transform how mobile games are monetized and distributed through its proprietary Game Hub Builder and LiveOps Builder technologies. CLICK HERE FOR VISUAL ASSETS For more information, please visit Aghanim's website. Press Contact: press@aghanim.com Follow Aghanim on LinkedIn, Twitter, Facebook, and Instagram for updates. About Aghanim:Aghanim, founded in June 2023, is a mobile gaming fintech company specializing in integrated commerce, liveops automation, community engagement, and payments. With a mission to revolutionize how mobile games are monetized and distributed, Aghanim's web-based game hubs empower developers to go direct-to-consumer and unlock new revenue streams. About SiftSift is the AI-powered fraud platform securing digital trust for leading global businesses. Our deep investments in machine learning and user identity, a data network scoring 1 trillion events per year, and a commitment to long-term customer success empower more than 700 customers to grow fearlessly. Brands including DoorDash, Yelp, and Poshmark rely on Sift to unlock growth and deliver seamless consumer experiences. Visit us at sift.com and follow us on LinkedIn. Photo - https://mma.prnasia.com/media2/2526472/Aghanim_x_Sift_partner.jpg?p=medium600
Hyundai and Waymo announce strategic partnership to offer safe and convenient autonomous driving experience for customers First phase of the partnership will begin with Waymo integrating its autonomous driving technology into Hyundai's all-electric IONIQ 5 SEOUL, South Korea and MOUNTAIN VIEW, Calif., Oct. 4, 2024 /PRNewswire/ -- Today, Hyundai Motor Company and Waymo announced they have entered into a multi-year, strategic partnership. In the first phase of this partnership, the companies will integrate Waymo's sixth-generation fully autonomous technology – the Waymo Driver – into Hyundai's all-electric IONIQ 5 SUV, which will be added to the Waymo One fleet over time. Hyundai and Waymo Enter Multi-Year, Strategic Partnership The IONIQ 5 vehicles destined for the Waymo fleet will be assembled at the new Hyundai Motor Group Metaplant America (HMGMA) EV manufacturing facility in Georgia and then integrated with Waymo's autonomous technology. The companies plan to produce a fleet of IONIQ 5s equipped with Waymo's technology in significant volume over multiple years to support Waymo One's growing scale. Initial on-road testing with Waymo-enabled IONIQ 5s will begin by late 2025 and become available to Waymo One riders in the years to follow. "We are thrilled to partner with Hyundai as we further our mission to be the world's most trusted driver," said Tekedra Mawakana, co-CEO, Waymo. "Hyundai's focus on sustainability and strong electric vehicle roadmap makes them a great partner for us as we bring our fully autonomous service to more riders in more places." "Hyundai and Waymo share a vision to improve the safety, efficiency and convenience of how people move," said José Muñoz, president and global COO of Hyundai Motor Company, and president and CEO of Hyundai Motor North America. "Waymo's transformational technology is improving road safety where they operate, and the IONIQ 5 is the ideal vehicle to scale this further. The team at our new manufacturing facility is ready to allocate a significant number of vehicles for the Waymo One fleet as it continues to expand. Importantly, this is the first step in the partnership between the two companies and we are actively exploring additional opportunities for collaboration." "We recently announced the launch of Hyundai Motor Company's autonomous vehicle foundry business to provide global autonomous driving companies with vehicles capable of implementing SAE Level 4 or higher autonomous driving technology," said Chang Song, President and Head of Hyundai Motor Group's Advanced Vehicle Platform (AVP) Division. "There is no better partner for our first agreement in this initiative than industry-leader Waymo." The Hyundai IONIQ 5 will be delivered to Waymo with specific autonomous-ready modifications like redundant hardware and power doors. The award-winning, all-electric vehicle will enable long driving shifts on a single charge, and its 800-volt architecture will minimize time out of service with some of the industry's fastest charging speeds available. The IONIQ 5's well-appointed and spacious interior will offer plenty of legroom, headroom, and rear cargo space for a comfortable rider experience. WaymoWaymo is an autonomous driving technology company with a mission to be the most trusted driver. Since our start as the Google Self-Driving Car Project in 2009, Waymo has been focused on building, deploying, and commercializing the World's Most Experienced Driver™ technology to improve the world's access to mobility while saving thousands of lives now lost to traffic crashes. The Waymo Driver powers Waymo One, the world's first fully autonomous ride-hailing service. To date, Waymo has autonomously driven tens of millions of miles on public roads and tens of billions of miles in simulation, across 13+ U.S. states. For more: www.waymo.com. About Hyundai Motor CompanyEstablished in 1967, Hyundai Motor Company is present in over 200 countries with more than 120,000 employees dedicated to tackling real-world mobility challenges around the globe. Based on the brand vision 'Progress for Humanity,' Hyundai Motor is accelerating its transformation into a Smart Mobility Solution Provider. The company invests in advanced technologies such as robotics and Advanced Air Mobility (AAM) to bring about revolutionary mobility solutions while pursuing open innovation to introduce future mobility services. In pursuit of a sustainable future for the world, Hyundai will continue its efforts to introduce zero-emission vehicles with industry-leading hydrogen fuel cell and EV technologies. More information about Hyundai Motor and its products can be found at: https://www.hyundai.com/worldwide/en/ or Newsroom: Media Hub by Hyundai
SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in revenue and infrastructure. The company aims to double sales of IDT Biologika by 2028 through new business projects and operational efficiency. The company will invest in high-growth businesses such as stage cell and gene therapy (CGT) and recombinant vaccine. SK bioscience will accelerate its global push based on the complementary capabilities of both companies. SEONGNAM, South Korea, Oct. 2, 2024 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced the successful completion of its acquisition of a controlling stake in a German company, IDT Biologika, one of the top 10 global vaccine contract development manufacturing organizations (CDMO). (from left) SK bioscience President and CEO Jaeyong Ahn and Klocke Group CEO Carsten Klocke on the signing ceremony in June In June 2024, SK bioscience has signed an agreement with Klocke Group, a German biopharmaceutical group, to acquire a controlling stake in IDT Biologika, Klocke Group's affiliate. As part of this transaction, Klocke Group will retain a 40% stake in IDT Biologika while investing approximately KRW 76 billion to acquire a 1.9% stake in SK bioscience. This cross-shareholding agreement is designed to strengthen their partnership, which is built on mutual trust in each company's operational capabilities and growth potential. With the acquisition complete, SK bioscience is set to focus on promoting the organic and systematic integration of both companies to enhance management efficiency and drive business expansion. The company plans to double IDT Biologika's annual sales by 2028 and improve its EBITDA (earnings before interest, taxes, depreciation, and amortization), targeting up to 25% of its sales. Leveraging the benefits of the IDT Biologika acquisition, SK bioscience also aims to achieve KRW 1 trillion (appx. USD 757.6 million) in consolidated sales within the next five years. The company's growth is expected to accelerate with the launch of next-generation pneumococcal vaccines, fueling its further expansion beyond 2028, and to see the significant improvements in its financial performance. The company will first seek to maximize the utilization rate of IDT Biologika's manufacturing facilities. In particular, the company plans to increasingly utilize some of IDT Biologika's DS (drug substance) and DP (drug product) high-performance production lines, such as the large-dose vial line, for potential major projects with global pharmaceutical companies. In addition, the company will optimize the lyophilized vial line to extend the existing contracts and win contracts for promising clinical pipelines and late-stage cell and gene therapy (CGT) projects. With additional cell line manufacturing and recombinant vaccine development technology, the company plans to pursue new CDMO contracts for mid- to large-scale products. SK bioscience will also invest in high-growth businesses such as the pre-filled syringes (PFS), recombinant vaccine, and CGT, which includes oncolytic viruses (OV), adeno-associated viruses (AAV), and lentiviruses (LV). Additionally, the company will transfer its technology and production to IDT Biologika for key products such as flu, shingles, chickenpox, and typhoid vaccines. Moving forward, SK bioscience undertakes key initiatives to improve IDT Biologika's short-term operational efficiency and profitability, including enhancing batch operational efficiency and raw material management, streamlining the supply chain, and improving quality management and operational management. SK bioscience believes that, given IDT Biologika's proven track record of technology and expertized talents, business expansion and operational improvements will proceed swiftly. IDT Biologika has maintained long-standing CDMO partnerships with over 15 of the world's major biotech and pharmaceutical companies, as well as research institutions. In addition to manufacturing vaccines for viral diseases such as COVID-19, the company has experience in contract manufacturing of various biopharmaceuticals. Takeda is one such company that IDT has partnered with many years for its dengue vaccine. Moreover, IDT Biologika has also the capability to expand into the CGT business especially as the producer of one of the few worldwide FDA and EMA-approved oncolytic viral therapies of a global player. The CGT business is one of the future growth engines of SK bioscience. To ensure rapid management stabilization and synergies, key executives from both companies including Carsten Klocke, CEO of the Klocke Group, and Jaeyong Ahn, President and CEO of SK bioscience, will serve on IDT Biologika's Advisory Board. The advisory board will ensure IDT Biologika's independent management while carrying out cultural integration. Dr. Sally Choe, Head of Development HQ of SK bioscience, has been named as co-CEO of IDT Biologika along with Dr. Ulrich Valley. Dr. Choe, who holds a Master and Ph.D. in Pharmaceutics from the University of Michigan, has worked for global pharmaceutical companies such as Pfizer-Bristol-Myers Squibb (BMS) and Parexel Regulatory Consulting firm. She has 12 years of tenure at the U.S. Food and Drug Administration (FDA), where she served as a Deputy Director in the Office of Translational Sciences (OTS) and as Super Office Director of the Office of Generic Drugs (OGD). Dr. Ulrich Valley, Co-CEO of IDT Biologika, said, "I am convinced that this milestone will contribute to future growth and to our vision of a leading CDMO. This global strategic cooperation is an important driver for our innovative strength, competitiveness and sustainable success, built on a foundation of trust and common goals. I am certain that we, SK bioscience and IDT Biologika, can achieve great things together by combining our competences and capabilities." Jaeyong Ahn, President and CEO of SK bioscience, said, "With the successful completion of IDT Biologika acquisition, we are rapidly stabilizing management as SK bioscience and IDT Biologika now unite one family. The capabilities of the two companies are expected to generate significant synergies, and we will accelerate our global expansion." About SK bioscience SK bioscience is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions. - SK bioscience Website- SK bioscience Linkedin ContactSK bioscience Communications TeamChanghyun Jin(jin99@sk.com)Jeannie S. Pak(j.pak@sk.com)
MELBOURNE, Australia, Sept. 26, 2024 /PRNewswire/ -- Firmable, the Australian tech start-up known for its deep local B2B data, has launched its Australian Construction Database – the first comprehensive mapping and standardisation of data in one of Australia's largest industries. This product opens new opportunities for businesses targeting the construction industry, by providing accurate, up-to-date insights into companies and contacts for more effective sales and marketing. Firmable's New Construction Database The construction industry, despite being highly regulated, is fragmented with a high proportion of small businesses and a lack of standardised classifications, making it difficult to find high-quality business opportunities. Firmable has addressed this by defining and categorising construction data, introducing clear segmentation and sub-sector identification for the first time. Co-founded by Leigh Jasper, Paul Perrett, and Karthik Venkatasubramanian, the Firmable team brings deep expertise and a proven track record in the construction industry, including their success at Aconex, which was acquired by Oracle for $1.6 billion. Their experience and networks have shaped Firmable's Construction Database, positioning it as the go-to data resource for the Australian construction sector. Leigh Jasper, Co-Founder and Co-CEO of Firmable, commented on the construction industry's challenges: "The construction sector is a cornerstone of Australia's economy employing around 1.2 million people. Despite the size of the industry, most activity is driven by sole traders or small businesses, so the industry has remained unmapped from a data perspective – until now. Our Construction Database transforms this landscape by bridging the data gap, providing accurate, detailed insights that enable businesses to find customers and connect with the right people to drive their growth." Matt Perrott, Co-founder and CEO of BuildPass, shared his experience: "The depth of construction data that Firmable has is unmatched by anyone in the Australian market. The ability to segment by specific construction sub-sectors, organisation types, specialisations, and more, allows us to target the right companies and decision-makers better than ever before. It's a breakthrough for anyone selling into construction." Key features of Firmable's Construction Database: Comprehensive data mapping: Search and filter across the construction industry by business type, specialisation, organisation type or even pre-qualification. Key contact data: Access to key contacts, including emails and phone numbers, across the Australian construction industry. Industry-specific filters: Advanced filtering options tailored to construction sectors, licences, locations, and other relevant criteria. Deep data dimensions: Detailed insights into each construction company, enabling a more informed and targeted approach to market engagement. With this launch, Firmable continues to solidify its position as Australia's leading B2B database platform, offering the most comprehensive and accurate data for businesses across all major industries. Firmable's Construction Module is now in Beta and available for companies looking to accelerate their growth through better business data. Contact Firmable. About Firmable Firmable is Australia's definitive B2B database platform, helping businesses drive smarter decisions and outperform by knowing more about their leads, customers, and candidates than ever before. The platform provides access to the largest database of companies in one place with a rich set of attributes, allowing sales and marketing teams to accelerate growth, better engage with their customers, and save time by leveraging reliable market intelligence.
NEW YORK, Sept. 20, 2024 /PRNewswire/ -- US-based EvolutionIQ, a global leader in claims guidance technology, has signed on as the Council of Australian Life Insurers (CALI)'s first Life Partner as part of its corporate partner program. The CALI Partner Program is designed to foster collaboration and create a connected ecosystem of industry experts. CALI Life Partners share the industry's mission to make life insurance accessible, understandable and trusted. They are companies that support Australian life insurers to help Australians and their families have peace of mind about their future so they can live in the most healthy, confident and secure way. "We are pleased to welcome EvolutionIQ as CALI's inaugural Life Partner. The CALI Partner Program plays an important role in connecting our members to the latest innovators, like EvolutionIQ, that can move their businesses forward," said CALI CEO Christine Cupitt. "We want to work closely with each of our partners to strengthen and support the life insurance industry to deliver better customer experiences for millions of Australians on their best and worst days." Headquartered in New York, EvolutionIQ has expanded significantly since 2019. Its clients include major insurance carriers such as Sun Life, Reliance Matrix and Principal Financial. Their AI-powered software makes insurance claims processes more personalised, fair and cost-effective so that more people can recover faster and return to work. "We are committed to supporting the Australian life insurance ecosystem and being a CALI Life Partner enables us to specialise our products to meet the dynamic needs of the Australian markets," said EvolutionIQ's Co-CEO, Mike Saltzman. "Our partnership with CALI means we can contribute to and shape customer experiences in Australia, and ultimately help more people return to health and a livelihood sooner." About EvolutionIQEvolutionIQ pioneered Claims Guidance in 2019. Its explainable AI guides insurance claims professionals to their highest potential impact claims, improving the claimant experience and delivering better claim outcomes to claimants, carriers and their customers. EvolutionIQ serves the group disability, individual disability and workers' compensation markets worldwide. EvolutionIQ's AI native products have been adopted by 70% of the top 15 U.S. disability carriers and a growing list of workers' compensation carriers. The New York-based company employs 185 staff across the United States, Europe and Australia. For more information, visit evolutioniq.com and follow the company on LinkedIn. About CALIWe support Australians to make informed choices about their future and help them live in a healthy, confident and secure way over their lifetime. Our members' products and services give people peace of mind when making important decisions and provide a financial safety net during life's biggest challenges. We advocate for national policy settings that expand Australians' access to the life insurance protection that suits them when they need it most. CALI represents all life insurers and reinsurers in Australia. The Australian life insurance industry is today a $26.4billion industry, employing thousands of Australians and paying billions of dollars of benefits each year. To view CALI's corporate partners visit www.cali.org.au/about-us/#our-partners For more information, visit www.cali.org.au Media ContactJason KaplerVice President of MarketingEvolutionIQ(917) 740-5608Press@evolutioniq.com Logo - https://mma.prnasia.com/media2/1723642/EvolutionIQ_Logo.jpg?p=medium600Logo - https://mma.prnasia.com/media2/2509100/CALI_logo.jpg?p=medium600
A12 藝術空間
Co-CEO
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
